Vitura Health Limited · ASX:VIT
Vitura Health — Shareholder Meeting (November 2025)
26 slides from Vitura Health's shareholder meeting presentation, Nov 26, 2025
Slide 1: Presentation for 2025 Annual General Meeting
ASX ANNOUNCEMENT Presentation for 2025 Annual General Meeting 26 NOVEMBER 2025 Melbourne, Australia – Vitura Health Limited (ASX: VIT) (Vitura and Company) is pleased to release the attached 2025 AGM presentation that will be presented at the 2025 Annual General Meeting of the Company’s shareholders
Slide 2: About Vitura Health Limited (ASX: VIT)
About Vitura Health Limited (ASX: VIT) www.vitura.com.au Vitura Health Limited is diversified digital health business listed on the ASX (ASX: VIT) and, via its wholly owned subsidiaries, operates the following businesses: • www.burleighheadscannabis.com Burleigh Heads Cannabis operates the market le
Slide 3: Forward-looking statements
Authorised by Robert Iervasi, Chair and Non-Executive Director Contact Vitura Health Limited Media enquiries Robert Iervasi Dieter Lehmann Chair Nominis Communications 1300 799 491 +61 427 672 995 info@vitura.com.au dieter@nominis.me Forward-looking statements For personal use only This announcement
Slide 4: 2025 Annual General Meeting
For personal use only 2025 ANNUAL GENERAL MEETING AND COMPANY UPDATE WEDNESDAY, 26 NOVEMBER 2025 Investor Presentation February 2023
Slide 5: Disclaimer applying to this presentation
Disclaimer applying to this presentation The following disclaimer applies to this presentation (Presentation) You are therefore advised to read this disclaimer carefully before reading or making any other use of this Presentation or any information contained in this Presentation. This Presentation h
Slide 6: Introductions
Introductions For personal use only Robert Iervasi Geoff Cockerill Tom Howitt Chair CEO CFO and Company Secretary Vitura Health Limited 2025 Annual General Meeting 3
Slide 7: Agenda
For personal use only AGENDA • Vision and Mission for FY2026 • Company Overview • FY2025 at a Glance • FY2026 Strategy in Action • FY2026 Priorities • Q&A Vitura Health Limited 2025 Annual General Meeting 4
Slide 8: FY2026 Vision and Mission
For personal use only FY2026 VISION AND MISSION 5
Slide 9: Vision and Mission for FY2026
Vision and Mission for FY2026 For personal use only Vision // To lead the future of healthcare access in specialty and emerging therapies. Mission // To build a connected ecosystem of patients, clinicians, pharmacies and suppliers through a seamless platform that delivers trusted access to specialty
Slide 10: Company Overview
For personal use only COMPANY OVERVIEW 7
Slide 11: Vitura's Unique Digital Health Ecosystem
Vitura’s Unique Digital Health Ecosystem For personal use only Vitura captures value at multiple points, supporting sustainable business growth. Vitura Health Limited 2025 Annual General Meeting 8
Slide 12: A Growing Portfolio of Interconnected Brands
A Growing Portfolio of Interconnected Brands For personal use only Vitura Health Limited 2025 Annual General Meeting 9
Slide 13: Company Information (as at November 2025)
Company Information (as at 24 November 2025) Shares On Issue 662,741,837 For personal use only Market Capitalisation (at 6.6 cents) $43.7M Charlie Shahin AO (17.28%) Sarah Jansen (13.02%) Guy Headley (7.56%) Substantial Shareholders Jessimine Jansen (7.56%) Cronos Group Inc. (8.33%) Matua Jansen (5.
Slide 14: FY2025 at a Glance
For personal use only FY2025 AT A GLANCE 11
Slide 15: FY2025 Financials at a Glance
FY2025 Financials at a Glance OPERATING NORMALISED NPAT EBITDA For personal use only REVENUE EBITDA $124.04M $7.63M $8.81M $3.06M Up 23.5% on FY2024 Normalised to provide a Down 5.8% on FY2024 Up 0.14% on FY2024 clearer view of underlying performance NORMALISED NPAT NORMALISED EPS DIVIDEND $3.88M 0.
Slide 16: Q1 FY2026 Key Takeaways
Q1 FY2026 Key Takeaways Q1 of FY2026 has started well on several fronts, including: For personal use only o Annualised revenue is more than 13% up on the same figure for FY2025 o Normalised OPEX is nearly 8% down against budget forecasts o Our OPEX efficiency is less than 21%, improved from 24% in F
Slide 17: FY2026 Strategy in Action
For personal use only FY2026 STRATEGY IN ACTION 14
Slide 18: FY2026 Strategy in Action
FY2026 Strategy in Action For personal use only STRENGTHEN EXPAND STRENGTHEN TEAM AND CUSTOMER TECHNOLOGY FINANCIAL MARKET COMPANY AND MARKET ENHANCEMENT IMPROVEMENT POSITION CULTURE BASE Vitura Health Limited 2025 Annual General Meeting 15 15
Slide 19: Canview – A Recognised Leader in the Market
Canview – A Recognised Leader in the Market For personal use only Vitura Health Limited 2025 Annual General Meeting 16
Slide 20: Acquisitions Driving Growth – Doctors on Demand
Acquisitions Driving Growth – Doctors on Demand Doctors on Demand (DoD) – A Leader in Australian Telehealth • DoD was acquired by Vitura in October 2023 For personal use only • 24/7, 365-day nationwide GP telehealth services • More than 350 doctors registered on the DoD platform • Continued strong g
Slide 21: Acquisitions Driving Growth – Candor and Releaf
Acquisitions Driving Growth – Candor and Releaf • Candor Medical was acquired by Vitura in February 2025 For personal use only • Candor delivered an additional 15,000 active patients • Forms centrepiece of new “Specialty Clinics” division • Flora Holdings JV (in which Vitura holds 42.5%) acquired th
Slide 22: Candor expansion with new website
Candor expansion with new website First visual cue of the activation plan that aims to reset For personal use only sentiment and build reputation via multiple touchpoints, delivering: awareness, acquisition, retention and advocacy. • Mobile-first optimisation and modern design, addressing key pain p
Slide 23: FY2026 Priorities
For personal use only FY2026 PRIORITIES 20
Slide 24: FY2026 Priorities
FY2026 Priorities Our major priorities for FY2026 are: For personal use only • Increasing patient acquisition and retention; • Producing a consistent supply of quality doctors; • Scaling our successful Doctors on Demand service; • Improving margins; • Technology investment in Canview; and • Keeping
Slide 25: Summary
Summary For personal use only • Executing well against strategic reset • Proven delivery and execution in the marketplace • New acquisitions integrating well and growing • Medical consulting and service fees rising strongly • Clinical care quality a benchmark for telehealth • New verticals enhancing
Slide 26: Questions and Answers
For personal use only QUESTIONS AND ANSWERS 23